Catalyst Wire Dossier Catalyst Wire Dossier

Absnow II Absorbable Atrial Septal Defect Closure System

· Lifetech Scientific (Shenzhen) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Absnow II Absorbable Atrial Septal Defect Closure System, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy [NA]

See pricing